Protein Forest Expands into Europe
News Jan 09, 2009
Protein Forest© announced that it has opened new business in Europe. Led by newly appointed Robert Marchmont, Ph.D. the European division will be headquartered in Newcastle upon Tyne, UK and will include office space and laboratory facilities to support sales, product demonstrations, applications development and collaborative projects with European customers.
Dr. Marchmont joins Protein Forest as European Business Director and brings with him over 25 years experience in the Life Science industry most recently with GE Healthcare. His particular focus on proteomics technologies and breadth of business expertise makes him an ideal appointment to this role.
“We are delighted to welcome Bob to the Protein Forest team and look forward to him setting up dedicated sales, a customer support team and distribution networks within Europe.” said Russell Garlick, Ph.D., President and CEO of Protein Forest. “There is growing confidence in the proteomics field applying our digital ProteomeChip (dPC™) sample preparation technology for mass spectrometry based proteomics and there are particular advantages to applying the dPC to aspects of targeted proteomics within clinical research.”
He added, “This confidence is highlighted particularly by the sustained investment we are receiving and customers’ purchases in such challenging times that exist today”.
Dr Marchmont commented, “I am delighted to be joining Protein Forest and to showcasing the benefits of our innovative product portfolio to European proteomic scientists. The Protein Forest dPC technology brings new advancements in data quality and speed to results for researchers applying mass spectrometry to their work.”
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
Discovery Provides Hope for New Vaccine Against Flesh-eating BacteriaNews
Researchers at Houston Methodist have solved a 100-year-old mystery, providing them a possible key to unlock a pathway for treating diseases caused by flesh-eating bacteria.READ MORE